{
    "code": "02024171",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02024171",
    "time": "2020-10-16 03:36:35",
    "許可證字號": "衛署藥輸字第024171號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/03\/09",
    "發證日期": "94\/03\/09",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00202417100",
    "中文品名": "始立膜衣錠100\/25\/200毫克",
    "英文品名": "STALEVO FILM-COATED TABLETS 100\/25\/200MG",
    "適應症": "表現藥效終期運動功能波動現象，以左多巴\/多巴脫羧基脢抑制劑無法達到穩定治療效果之巴金森氏症病人。",
    "劑型": "116膜衣錠",
    "包裝": "8-1000顆塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "LEVODOPA, ENTACAPONE, CARBIDOPA MONOHYDRATE",
    "限制項目": "02輸　入 54依本署89、12、12衛署藥字第0890035812號公告事項九得免除國內進行臨床試驗之特殊醫療需要之新藥",
    "申請商名稱": "0901301200  美時化學製藥股份有限公司",
    "申請商地址": "台北市信義區松仁路277號17樓",
    "主製造廠": [
        {
            "製造廠名稱": "FFI0013500  ORION CORPORATION",
            "製造廠廠址": "ORIONINITE 1, FIN-02200 ESPOO, FINLAND",
            "製造廠公司地址": "",
            "製造廠國別": "FINLAND",
            "製程": "成品製造廠"
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "FCH0088200  NOVARTIS PHARMA. AG",
            "製造廠廠址": "LICHTSTRASSE 35,CH-4056,BASLE, SWITZERLAND",
            "製造廠公司地址": "",
            "製造廠國別": "SWITZERLAND",
            "製程": "許可證持有者"
        },
        {
            "製造廠名稱": "FFI0031000  Orion Corporation",
            "製造廠廠址": "Joensuunkatu 7, Salo 24100, Finland",
            "製造廠公司地址": "",
            "製造廠國別": "FINLAND",
            "製程": "包裝"
        }
    ],
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1208002900",
            "成分名稱": "LEVODOPA",
            "含量描述": "",
            "含量": "100.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "1208008800",
            "成分名稱": "ENTACAPONE",
            "含量描述": "",
            "含量": "200.0000000000",
            "單位": "MG"
        },
        {
            "成分類別": "主成分",
            "成分代碼": "2408000420",
            "成分名稱": "CARBIDOPA MONOHYDRATE",
            "含量描述": "",
            "含量": "27.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "024171_Stalevo film-coated tablets 10025200mg-108-06-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024171&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單電子檔_024171_始立膜衣錠100-25-200毫克-108-11-19.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024171&Seq=001&Type=9"
        },
        {
            "title": "核定本-108-12-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02024171&Seq=005&Type=8"
        }
    ]
}